Early Access

Back to CVS

CVS HEALTH Corp Cash & Equivalents 2006-2025 | CVS

Beta

What is cash & equivalents?

Cash and cash equivalents can be defined as the most liquid assets on a company's balance sheet, including cash on hand and short-term investments maturing within 90 days.

What is CVS HEALTH Corp's current cash & equivalents?

CVS HEALTH Corp (CVS) annual cash & equivalents for 2025 was $8.45B, a 1.55% decline from 2024. CVS HEALTH Corp cash & equivalents for the quarter ending December 31, 2025 was $8.45B.

What was CVS HEALTH Corp's cash & equivalents in 2024?

CVS HEALTH Corp annual cash & equivalents for 2024 was $8.59B, a 4.76% increase from 2023.

What was CVS HEALTH Corp's cash & equivalents in 2023?

CVS HEALTH Corp annual cash & equivalents for 2023 was $8.20B, a 36.69% decline from 2022.

What is CVS HEALTH Corp's 5-year cash & equivalents CAGR?

CVS HEALTH Corp cash & equivalents grew at a compound annual growth rate (CAGR) of 1.48% from FY2020 to FY2025, going from $7.85B to $8.45B over 5 years.

Cash & Equivalents History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Stable
CAGR+1.5%
FY2020
$7.85B
FY2025
$8.45B
0607080910111213141516171819202122232425
5 years selected
Cash & Equivalents History
PeriodValueChangeSource
FY2025$8.45B-1.5%10-K
FY2024$8.59B+4.8%10-K
FY2023$8.20B-36.7%10-K
FY2022$12.95B+37.6%10-K
FY2021$9.41B+19.8%10-K
FY2020$7.85B+38.2%10-K
FY2019$5.68B+40.0%10-K
FY2018$4.06B+139.3%10-K
FY2017$1.70B-49.7%10-K
FY2016$3.37B+37.1%10-K
FY2015$2.46B-0.9%10-K
FY2014$2.48B-39.3%10-K
FY2013$4.09B+197.4%10-K
FY2012$1.38B-2.7%10-K
FY2011$1.41B-1.0%10-K
FY2010$1.43B+31.4%10-K
FY2009$1.09B-19.7%10-K
FY2008$1.35B+28.0%10-K
FY2007$1.06B+99.2%10-K
FY2006$530.0M-10-K
Company: CVS HEALTH CorpTicker: CVSSector: HealthcareIndustry: Retail-Drug Stores and Proprietary StoresView company profile →